Search the Newsreel

Bronstein, Gewirtz & Grossman, LLC Is Investigating AdaptHealth Corp. (AHCO) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against AdaptHealth Corp. (AHCO) after the company reported significantly lower-than-expected Q2 2026 revenue and adjusted EBITDA, along with a substantial reduction in full-year guidance. The firm encourages investors who purchased AdaptHealth securities to connect with …

AdaptHealth Corp. (AHCO) Securities Investigation Notice - Levi & Korsinsky

Levi & Korsinsky, LLP has issued a securities investigation notice for AdaptHealth Corp. (AHCO) after the company reported second-quarter 2026 revenue and earnings significantly below analyst expectations. Shares of AdaptHealth fell as much as 26% following the announcement of a $0.99 GAAP loss per …

AdaptHealth misses Q2 revenue and earnings estimates, shares drop 26%.

AdaptHealth Corp. (AHCO) reported a significant miss on Q2 2026 revenue and earnings estimates, with revenue at $740.3 million against an anticipated $847 million, and a GAAP loss of $0.99 per share compared to an expected loss of $0.15. This poor performance led to …

Kenneth Samet Bought 94% More Shares In AdaptHealth

Independent Director Kenneth Samet recently purchased US$150k worth of AdaptHealth (NASDAQ:AHCO) shares at US$6.38 each, increasing his holding by 94%. This insider buying activity, along with other purchases totaling US$511k over the last year, suggests a bullish sentiment despite the company's recent loss. Insiders …

AdaptHealth (AHCO) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer - Suzanne Foster Chief Financial Officer - Jason Clemens Full Conference Call Transcript Operator: Good day, everyone, and welcome to today's AdaptHealth Second Quarter 2026 …

AdaptHealth at Canaccord Genuity’s 46th annual growth conference: refocus deepens

AdaptHealth discussed its business transition at Canaccord Genuity's 46th Annual Growth Conference, focusing on organic growth, debt reduction, and core home medical equipment lines after divesting its diabetes business. The company highlighted strong sleep care demand and 16% Q2 2024 revenue growth, despite facing …

AdaptHealth (NASDAQ:AHCO) Trading Up 10.5% on Insider Buying Activity

AdaptHealth (NASDAQ:AHCO) saw its stock price increase by 10.5% due to significant insider buying activity, specifically by Director Kenneth A. Samet, who increased his holdings by 93.7% with a purchase worth nearly $150,000. Analyst sentiment is mixed but leans positive, with seven analysts rating …

AdaptHealth Sells Diabetes Unit to Sharpen Focus on Sleep, Respiratory Growth

Key Points Interested in AdaptHealth Corp.? Here are five stocks we like better. AdaptHealth is selling its roughly $600 million diabetes business to Cardinal Health and exiting certain e-commerce and drop-ship operations to simplify the company and focus on sleep, respiratory and home medical …

Adapthealth director Kenneth Samet buys $149,930 in shares

AdaptHealth Corp. director Kenneth Samet recently purchased 23,500 shares of company stock for $149,930, bringing his total holdings to 48,569 shares. This insider purchase occurs while AHCO stock is trading near its 52-week low, with InvestingPro analysis suggesting it is undervalued. The company recently …

Adapthealth director Dale Wolf buys $244,600 in company stock

Dale B. Wolf, a director at AdaptHealth Corp. (NASDAQ:AHCO), recently purchased 40,000 shares of company stock for $244,600 in early August 2026, with prices between $5.83 and $6.37 per share. These insider purchases occurred while AHCO shares traded near their 52-week low, and InvestingPro …

AdaptHealth (NASDAQ:AHCO) Director Purchases $149,930.00 in Stock

AdaptHealth (NASDAQ:AHCO) Director Kenneth Samet recently purchased 23,500 shares for $149,930, increasing his stake by 93.74%. Despite the purchase and analysts' "Moderate Buy" rating with a $10.29 price target, the stock fell 8.3% to $5.22, nearing its one-year low, with trading volume more than …

Time To Worry? Analysts Just Downgraded Their AdaptHealth Corp. (NASDAQ:AHCO) Outlook

Analysts have significantly downgraded their near-term forecasts for AdaptHealth Corp. (NASDAQ:AHCO), cutting both revenue and earnings per share estimates for 2026. The consensus now projects a substantial revenue reduction and a loss per share, leading to a 35% drop in the consensus price target. …

ADAPTHEALTH CORP. : LEERINK PARTNERS CUTS TARGET PRICE TO $7 FROM $12

Leerink Partners has reduced its target price for AdaptHealth Corp. (AHCO) shares from $12 to $7. This change reflects an updated outlook from the investment firm regarding the company's valuation. The article, sourced from Reuters, provides this key financial adjustment.

Why AdaptHealth Stock Plummeted This Week

Key Points AdaptHealth posted a huge earnings miss in Q2, and sales also came in below expectations. The company also lowered its fiscal performance targets for the year.10 stocks we like better than AdaptHealth › AdaptHealth(NASDAQ: AHCO) stock got crushed this week after the …

AdaptHealth Corp. $AHCO Shares Sold by Reinhart Partners LLC.

Reinhart Partners LLC reduced its stake in AdaptHealth Corp. by 26.4% in the second quarter, selling over 2.6 million shares but still retaining a significant holding. Despite this sale, other institutional investors increased their positions in AHCO. The stock currently holds a "Moderate Buy" …

AHCO Investors Have Opportunity to Join AdaptHealth Corp. Fraud Investigation with SBS Law

Schall, Brown & Schwartz LLP (SBS) is investigating potential securities law violations by AdaptHealth Corp. (NASDAQ: AHCO) on behalf of its investors. This investigation follows AdaptHealth's Q2 2026 financial results, where the company missed earnings estimates and significantly cut its full-year guidance, leading to …

AdaptHealth (AHCO) Reports A Net Loss And Goodwill Impairment, Is The Stock A Bargain?

AdaptHealth Corp. Just Missed Earnings; Here's What Analysts Are Forecasting Now

AdaptHealth Corp. (NASDAQ:AHCO) shares plunged 43% after missing Q2 earnings estimates, with revenues falling 13% short and the company reporting a statutory loss instead of a forecasted profit. Analysts have significantly cut revenue forecasts and now anticipate a loss for 2026, leading to a …

AHCO SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving AdaptHealth Corp.

SueWallSt, powered by Levi & Korsinsky LLP, has initiated an investigation into AdaptHealth Corp. (NASDAQ: AHCO) after the company significantly lowered its full-year 2026 revenue and adjusted EBITDA guidance, causing a stock drop of up to 26%. The investigation focuses on whether AdaptHealth made …

AdaptHealth (AHCO) Stock Faces Deeper Doubts After Profit Reset

Securities Fraud Investigation Into AdaptHealth Corp. (AHCO) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz has announced a securities fraud investigation into AdaptHealth Corp. (AHCO) following a significant drop in its stock price. This investigation comes after AdaptHealth reported a substantial earnings miss and cut its full-year 2026 adjusted EBITDA guidance, citing …

AdaptHealth Corp. Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into AdaptHealth Corp. (AHCO)

Levi & Korsinsky is investigating AdaptHealth Corp. (AHCO) after the company significantly cut its full-year 2026 adjusted EBITDA guidance. The reduction from an initial range of $680 million-$730 million to approximately $490 million-$520 million, a drop of $190 million-$210 million, caused a stock decline …

Stocks making big moves yesterday: AdaptHealth, UL Solutions, Ball, Tidewater, and Wayfair

This article highlights several stocks that experienced significant movement yesterday, August 4, 2026, due to their second-quarter earnings reports. AdaptHealth and UL Solutions saw declines after reporting disappointing results, while Ball's strong earnings were overshadowed by profitability concerns. In contrast, Tidewater and Wayfair both …

AdaptHealth Corp. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:AHCO)

AdaptHealth Corp. published its Q2 2026 earnings call presentation on August 5, 2026. The company reported an EPS of -$0.07, missing estimates by $0.23, and revenue of $740.31M, down 7.50% year-over-year and missing estimates by $106.47M. This information was shared in conjunction with their …

AdaptHealth Agrees to Sell Diabetes Business for $235M, Subject to Adjustments

AdaptHealth Corp. announced its second-quarter 2026 financial results, revealing a definitive agreement to sell its Diabetes Health business for $235 million in cash. This divestiture is part of AdaptHealth's strategy to focus on its core Sleep Health, Respiratory Health, and Wellness-at-Home segments. The company …

AdaptHealth (NASDAQ:AHCO) Releases Quarterly Earnings Results

AdaptHealth Corp. 2Q 2026: Revenue $740.31M, Net income ($133.93M), EPS ($0.99) — 10-Q Summary

AdaptHealth Corp. reported its second-quarter 2026 results, showing a 12.7% increase in revenue year-over-year to $740.31 million. Despite revenue growth, the company recorded a net loss of $133.93 million and a diluted EPS of ($0.99), a significant decrease compared to the prior year's profit. …

AHCO INVESTOR ALERT: Investigation of AdaptHealth Corp. Announced by Holzer & Holzer, LLC

Holzer & Holzer, LLC has announced an investigation into AdaptHealth Corp. (NASDAQ: AHCO) regarding potential violations of federal securities laws. This comes after AdaptHealth revised its financial guidance and reported a decrease in cash flow from operations and negative free cash flow for Q2 …

Investigation launched into AdaptHealth after revised guidance and Q2 cash flow drop. AHCO $6.71 -$4.12 -38.04%

Holzer & Holzer, LLC has launched an investigation into AdaptHealth Corp. following the company's revised financial guidance and second-quarter 2026 results. AdaptHealth reported a decrease in cash flow from operations and a negative free cash flow, attributing the decline to the full-scale launch and …

Why AdaptHealth (AHCO) Stock Is Trading Lower Today

AdaptHealth Corp. (AHCO) stock significantly dropped by 39.5% after reporting disappointing second-quarter results and drastically cutting its full-year financial guidance. The company posted a loss of $0.99 per share and revenue of $740.3 million, both falling short of analyst expectations, and attributed the lowered …

AdaptHealth lowers outlook as new contract, manufacturer costs pressure margins

AdaptHealth has reduced its full-year financial outlook due to pressures from a new capitated agreement and unexpected manufacturer price increases. Despite a 12.7% increase in second-quarter revenue, implementation costs for a major contract and a $30 million impact from a manufacturer price hike negatively …

AdaptHealth plunges on Q2 results, narrows 2026 revenue guidance

[Computer key - 2nd quarter] jurgenfr * AdaptHealth is down ~42% in Tuesday morning trading after posting Q2 financial results that missed [https://seekingalpha.com/news/4624489-adapthealth-corp-gaap-eps-of-1_07-misses-by-1_22-revenue-of-740_3m-misses-by-106_47m] on both lines and revising its 2026 revenue guidance downwards. * Full-year net revenue is now seen at $2.85B-$2.89B compared to …

AdaptHealth Shares Sink After Earnings Miss and Lower Full-Year Guidance

AdaptHealth (NASDAQ:AHCO) shares plummeted after the company reported second-quarter 2026 results that missed Wall Street expectations and significantly cut its full-year financial outlook. The home medical equipment provider posted a quarterly loss of $0.99 per share and revenue of $740.3 million, both falling short …